About

For more than twenty years, I worked inside global capital markets. At Credit Suisse (later UBS), I advised ultra-high-net worth families, constructed portfolios, and helped investors navigate uncertainty. In that role, I oversaw approximately $5 billion in client assets and more than $700 million in advisory mandates.

Over time, a pattern became impossible to ignore. Entire areas of healthcare affecting half the population were almost invisible to capital because the system wasn’t designed to see it.

Women’s health is one of those gaps, and today healthcare stands at an inflection point. Across diagnostics, therapeutics, and longevity science, a new frontier of healthcare innovation is emerging, one markets are only beginning to understand.

Today my work focuses on identifying structural blind spots in capital allocation in places where markets systematically misprice risk, innovation, or long-term value.

This isn’t philanthropy. It’s performance with purpose. And the returns — economic and societal — speak for themselves.